Literature DB >> 23473667

Recognition of mono-ADP-ribosylated ARTD10 substrates by ARTD8 macrodomains.

Alexandra H Forst1, Tobias Karlberg, Nicolas Herzog, Ann-Gerd Thorsell, Annika Gross, Karla L H Feijs, Patricia Verheugd, Petri Kursula, Bianca Nijmeijer, Elisabeth Kremmer, Henning Kleine, Andreas G Ladurner, Herwig Schüler, Bernhard Lüscher.   

Abstract

ADP-ribosyltransferases (ARTs) catalyze the transfer of ADP-ribose from NAD(+) onto substrates. Some ARTs generate in an iterative process ADP-ribose polymers that serve as adaptors for distinct protein domains. Other ARTs, exemplified by ARTD10, function as mono-ADP-ribosyltransferases, but it has been unclear whether this modification occurs in cells and how it is read. We observed that ARTD10 colocalized with ARTD8 and defined its macrodomains 2 and 3 as readers of mono-ADP-ribosylation both in vitro and in cells. The crystal structures of these two ARTD8 macrodomains and isothermal titration calorimetry confirmed their interaction with ADP-ribose. These macrodomains recognized mono-ADP-ribosylated ARTD10, but not poly-ADP-ribosylated ARTD1. This distinguished them from the macrodomain of macroH2A1.1, which interacted with poly- but not mono-ADP-ribosylated substrates. Moreover, Ran, an ARTD10 substrate, was also read by ARTD8 macrodomains. This identifies readers of mono-ADP-ribosylated proteins, defines their structures, and demonstrates the presence of this modification in cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473667     DOI: 10.1016/j.str.2012.12.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  49 in total

Review 1.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

2.  ELTA: Enzymatic Labeling of Terminal ADP-Ribose.

Authors:  Yoshinari Ando; Elad Elkayam; Robert Lyle McPherson; Morgan Dasovich; Shang-Jung Cheng; Jim Voorneveld; Dmitri V Filippov; Shao-En Ong; Leemor Joshua-Tor; Anthony K L Leung
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

3.  Proteomics approaches to identify mono-(ADP-ribosyl)ated and poly(ADP-ribosyl)ated proteins.

Authors:  Christina A Vivelo; Anthony K L Leung
Journal:  Proteomics       Date:  2014-12-15       Impact factor: 3.984

4.  PARP10 suppresses tumor metastasis through regulation of Aurora A activity.

Authors:  Yahui Zhao; Xiaoding Hu; Li Wei; Dan Song; Juanjuan Wang; Lifang You; Hexige Saiyin; Zhaojie Li; Wenbo Yu; Long Yu; Jin Ding; Jiaxue Wu
Journal:  Oncogene       Date:  2018-03-08       Impact factor: 9.867

5.  Site-specific analysis of the Asp- and Glu-ADP-ribosylated proteome by quantitative mass spectrometry.

Authors:  Peng Li; Yuanli Zhen; Yonghao Yu
Journal:  Methods Enzymol       Date:  2019-07-24       Impact factor: 1.600

6.  Family-wide analysis of poly(ADP-ribose) polymerase activity.

Authors:  Sejal Vyas; Ivan Matic; Lilen Uchima; Jenny Rood; Roko Zaja; Ronald T Hay; Ivan Ahel; Paul Chang
Journal:  Nat Commun       Date:  2014-07-21       Impact factor: 14.919

7.  The macro domain as fusion tag for carrier-driven crystallization.

Authors:  Rebekka Wild; Michael Hothorn
Journal:  Protein Sci       Date:  2016-11-02       Impact factor: 6.725

8.  ARTC1-mediated ADP-ribosylation of GRP78/BiP: a new player in endoplasmic-reticulum stress responses.

Authors:  Gaia Fabrizio; Simone Di Paola; Annalisa Stilla; Monica Giannotta; Carmen Ruggiero; Stephan Menzel; Friedrich Koch-Nolte; Michele Sallese; Maria Di Girolamo
Journal:  Cell Mol Life Sci       Date:  2014-10-08       Impact factor: 9.261

9.  Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases.

Authors:  Florian Rosenthal; Karla L H Feijs; Emilie Frugier; Mario Bonalli; Alexandra H Forst; Ralph Imhof; Hans C Winkler; David Fischer; Amedeo Caflisch; Paul O Hassa; Bernhard Lüscher; Michael O Hottiger
Journal:  Nat Struct Mol Biol       Date:  2013-03-10       Impact factor: 15.369

Review 10.  New PARP targets for cancer therapy.

Authors:  Sejal Vyas; Paul Chang
Journal:  Nat Rev Cancer       Date:  2014-06-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.